Related references
Note: Only part of the references are listed.2-Azetidinones: Synthesis and biological evaluation as potential anti-breast cancer agents
Ramasatyaveni Geesala et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Histone deacetylases differentially regulate the proliferative phenotype of mouse bone marrow stromal and hematopoietic stem/progenitor cells
Neha R. Dhoke et al.
STEM CELL RESEARCH (2016)
Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives
Eshvendar Reddy Kasala et al.
TOXICOLOGY LETTERS (2015)
Nanoparticles generated by PEG-Chrysin conjugates for efficient anticancer drug delivery
Hui Zheng et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
S-adenosylmethionine limitation induces p38 mitogen-activated protein kinase and triggers cell cycle arrest in G1
Da-Wei Lin et al.
JOURNAL OF CELL SCIENCE (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
Nicole M. Davis et al.
ONCOTARGET (2014)
Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
Maroof Alam et al.
ONCOTARGET (2014)
Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors
Youichi Kawakita et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Prolidase Directly Binds and Activates Epidermal Growth Factor Receptor and Stimulates Downstream Signaling
Lu Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TIEG1 Inhibits Breast Cancer Invasion and Metastasis by Inhibition of Epidermal Growth Factor Receptor (EGFR) Transcription and the EGFR Signaling Pathway
Wei Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
Christopher H. Switzer et al.
MOLECULAR CANCER RESEARCH (2012)
Inhibition of Platelet-Derived Growth Factor Receptor Signaling Regulates Oct4 and Nanog Expression, Cell Shape, and Mesenchymal Stem Cell Potency
Stephen G. Ball et al.
STEM CELLS (2012)
Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
Kenji Takeuchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
Kathleen Aertgeerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Synthesis and cytotoxicity of novel chrysin derivatives
Kun Hu et al.
MEDICINAL CHEMISTRY RESEARCH (2011)
The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer
L. M. Privette Vinnedge et al.
ONCOGENE (2011)
Triple negative breast cancer - prognostic factors and survival
Tanja Ovcaricek et al.
RADIOLOGY AND ONCOLOGY (2011)
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
Yvonne Hui-Fang Teng et al.
BREAST CANCER RESEARCH (2011)
Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
Sunitha V. Bachawal et al.
BMC CANCER (2010)
Epidermal Growth Factor Receptor Expression in Breast Cancer Association With Biologic Phenotype and Clinical Outcomes
Mothaffar F. Rimawi et al.
CANCER (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
Targeting Breast Cancer Stem Cells
Suling Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Silencing Kinase-Interacting Stathmin Gene Enhances Erlotinib Sensitivity by Inhibiting Ser10 p27 Phosphorylation in Epidermal Growth Factor Receptor-Expressing Breast Cancer
Dongwei Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Receptor-Based Virtual Screening of EGFR Kinase Inhibitors from the NCI Diversity Database
Kiattawee Choowongkomon et al.
MOLECULES (2010)
Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
M. K. Wendt et al.
ONCOGENE (2010)
Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells
Venkata Lokesh Battula et al.
STEM CELLS (2010)
Permanently Blocked Stem Cells Derived From Breast Cancer Cell Lines
Gangadharan B. Sajithlal et al.
STEM CELLS (2010)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
The Steroid Receptor Coactivator-1 Regulates Twist Expression and Promotes Breast Cancer Metastasis
Li Qin et al.
CANCER RESEARCH (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation
Kathryn Loving et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Jab1 is a target of EGFR signaling in ER alpha-negative breast cancer
Jiaxu Wang et al.
BREAST CANCER RESEARCH (2008)
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Matthew J. Grimshaw et al.
BREAST CANCER RESEARCH (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Marc Tischkowitz et al.
BMC CANCER (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity
Dexing Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
Anna L. Stratford et al.
BREAST CANCER RESEARCH (2007)
Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration
Amitava Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Amide bond formation and peptide coupling
CAGN Montalbetti et al.
TETRAHEDRON (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Disposition and metabolism of the flavonoid chrysin in normal volunteers
T Walle et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
